Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Experimental models for antiphospholipid studies

A E Gharavi1, A L Aron

  • 1LSU Medical Center, New Orleans 70112.

Haemostasis
|May 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intrauterine fetal death in mice caused by cytomegalovirus-derived peptide induced aPL antibodies.

Lupus·2004
Same author

The molecular basis of antiphospholipid syndrome.

Lupus·2003
Same author

Infections and antiphospholipid antibodies.

Le Journal medical libanais. The Lebanese medical journal·2002
Same author

Origin of antiphospholipid antibodies.

Rheumatic diseases clinics of North America·2001
Same author

International classification criteria for antiphospholipid syndrome: synopsis of a post-conference workshop held at the Ninth International (Tours) aPL Symposium.

Lupus·2001
Same author

Anticardiolipin antibodies: importance, controversies, discrepancies; the need for guidelines and calibrators.

Clinical and experimental rheumatology·2001

Researchers investigated anti-phospholipid antibodies (APA) using three animal models. Studies involved passive transfer, active immunization, and beta 2 glycoprotein I immunization, revealing distinct antibody specificities.

Area of Science:

  • Immunology
  • Reproductive Medicine
  • Autoimmunity

Background:

  • Anti-phospholipid antibodies (APA) are implicated in recurrent fetal loss.
  • Understanding APA pathogenicity is crucial for managing pregnancy complications.

Purpose of the Study:

  • To investigate the role and specificities of anti-phospholipid antibodies (APA) in experimental animal models.
  • To characterize antibody populations targeting phospholipids and beta 2 glycoprotein I (beta 2GPI).

Main Methods:

  • Passive transfer of patient-derived IgG APA to pregnant mice.
  • Active immunization of mice with human monoclonal APA.
  • Immunization with beta 2 glycoprotein I (beta 2GPI) and antibody characterization using affinity chromatography.

Related Experiment Videos

Main Results:

  • Two distinct antibody populations were identified: one specific for beta 2GPI, and another with dual specificity for phospholipids (PL) and beta 2GPI.
  • Experimental models demonstrated different approaches to studying APA.
  • Purified IgG APA from patients with recurrent fetal loss was used in passive transfer.

Conclusions:

  • Experimental animal models provide valuable insights into anti-phospholipid antibody (APA) function.
  • Antibodies targeting beta 2 glycoprotein I (beta 2GPI) play a significant role, with some exhibiting dual specificity for phospholipids (PL).
  • Further research into these antibody specificities may inform therapeutic strategies for anti-phospholipid syndrome.